Loading...
The CDC on Friday warned physicians to avoid using gadolinium-containing MRI contrast agents when possible in patients with advanced renal failure because of the risk for a serious skin disease.
In an article in MMWR, gadolinium agents were linked to nephrogenic fibrosing dermopathy (NFD), which can cause thickening and hardening of the skin. Researchers conducted a matched case-control study that included 19 cases from a St. Louis hospital. In multivariate analysis, patients with renal disease who developed NFD were nearly nine times as likely to have been exposed to gadolinium contrast agents in the previous year as those who did not develop the skin condition. Patients receiving peritoneal dialysis appeared to be at greater risk than those receiving hemodialysis.
Comment
Link: MMWR article (Free)
Link: Washington Post story (Free)